New York Attorney General Letitia James (Bebeto Matthews/AP Images)
February 26, 2024 02:00 PM ESTUpdated 04:42 PM
Pharma
FDA+

New York AG calls for 'more strin­gen­t' Sin­gu­lair safe­ty warn­ings

Nicole DeFeudis

Editor

New York At­tor­ney Gen­er­al Leti­tia James wants an “ur­gent” re­view of the safe­ty la­bel for a decades-old asth­ma and al­ler­gy med­ica­tion.

James last week …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Will CRISPR mat­ter?

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times